Open Access. Powered by Scholars. Published by Universities.®

Digital Commons Network™

Open Access. Powered by Scholars. Published by Universities.®

Law

Institution
Keyword
Publication Year
Publication
Publication Type
File Type

Articles 301 - 330 of 184090

Full-Text Articles in Entire DC Network

History And Tradition Is Not Originalism — Nor A Good Idea, Kermit Roosevelt Iii, Sarah Choudhary Sep 2026

History And Tradition Is Not Originalism — Nor A Good Idea, Kermit Roosevelt Iii, Sarah Choudhary

Seton Hall Journal of Legislation and Public Policy

No abstract provided.


The First Amendment Does Too Much To Protect Child Predators: An Examination Of Child Erotica Under First Amendment Jurisprudence, Michael Fuccile Sep 2026

The First Amendment Does Too Much To Protect Child Predators: An Examination Of Child Erotica Under First Amendment Jurisprudence, Michael Fuccile

Seton Hall Journal of Legislation and Public Policy

No abstract provided.


Modernizing And Clarifying Family Laws: The New Jersey Law Revision Commission’S Examination Of Self-Representation, Domestic Violence, And Parental Rights, Barbara B. Rivera, Whitney G. Schlimbach, Candy Ley Velazquez, Kyle M. Ryan Sep 2026

Modernizing And Clarifying Family Laws: The New Jersey Law Revision Commission’S Examination Of Self-Representation, Domestic Violence, And Parental Rights, Barbara B. Rivera, Whitney G. Schlimbach, Candy Ley Velazquez, Kyle M. Ryan

Seton Hall Journal of Legislation and Public Policy

No abstract provided.


Recreational Cannabis In The Workplace: The Importance Of Implementing Clear Standards For Employers To Determine Whether Employees Are Impaired At Work, Jessica Shinski Sep 2026

Recreational Cannabis In The Workplace: The Importance Of Implementing Clear Standards For Employers To Determine Whether Employees Are Impaired At Work, Jessica Shinski

Seton Hall Journal of Legislation and Public Policy

No abstract provided.


A Dangerous Precedent: How State V. Blevins Fails To Account For Self-Defense In Intimate Partner Violence Scenarios, Arooj Agha Sep 2026

A Dangerous Precedent: How State V. Blevins Fails To Account For Self-Defense In Intimate Partner Violence Scenarios, Arooj Agha

Seton Hall Journal of Legislation and Public Policy

No abstract provided.


Mythbusting Cybersecurity Information Sharing And Antitrust, Terence Check Sep 2026

Mythbusting Cybersecurity Information Sharing And Antitrust, Terence Check

Journal of Business & Technology Law

No abstract provided.


Mandatory Arbitration: Privatizing Justice, And The Quiet Displacement Of The Civil Jury Trial, Leo Clarke Sep 2026

Mandatory Arbitration: Privatizing Justice, And The Quiet Displacement Of The Civil Jury Trial, Leo Clarke

Journal of Business & Technology Law

No abstract provided.


Programmed To Please, Optimized For Obsession, Ela Ender Sep 2026

Programmed To Please, Optimized For Obsession, Ela Ender

Journal of Business & Technology Law

No abstract provided.


Ames V. Ohio Department Of Youth Services: Walking The Disparate Treatment Tightrope, Jonathan Lehr Sep 2026

Ames V. Ohio Department Of Youth Services: Walking The Disparate Treatment Tightrope, Jonathan Lehr

Journal of Business & Technology Law

No abstract provided.


Reimagining The Path Forward: Preparing And Promoting The Next Generation Of Arbitrators Through Innovative Mentorship, Disclosure, And Transparency, Homer C. La Rue Sep 2026

Reimagining The Path Forward: Preparing And Promoting The Next Generation Of Arbitrators Through Innovative Mentorship, Disclosure, And Transparency, Homer C. La Rue

Pepperdine Dispute Resolution Law Journal

The article addresses a pivotal moment for the labor-management arbitration profession. As demographic changes and the growing complexity of labor relations coincide with a decline in the number of qualified arbitration professionals, Professor La Rue emphasizes the critical role senior arbitrators play as mentors and gatekeepers for the next generation. The piece explores mentorship models, including the traditional “Legacy Method” and initiatives designed to expand opportunities for underrepresented groups, such as the Ray Corollary Initiative. The article also offers actionable recommendations to advance disclosure and transparency, including: (1) reducing barriers to entry for new arbitrators; (2) establishing a formal mentorship …


An Open Door Policy: A Contemporary Analysis Of The Continuing Need For Court-Connected Civil Compulsory Arbitration Programs, Joshua D. Rogers Sep 2026

An Open Door Policy: A Contemporary Analysis Of The Continuing Need For Court-Connected Civil Compulsory Arbitration Programs, Joshua D. Rogers

Pepperdine Dispute Resolution Law Journal

Compulsory arbitration could be a crucial instrument in addressing an impending renewed litigation explosion. In the latter half of the twentieth century, numerous courts implemented court-connected civil compulsory arbitration programs to help address the substantial problems created by historic increases in civil litigation. Without much fanfare, these programs have been successfully operating to achieve the goals envisioned at their creation—improving judicial economy and efficiency. Despite the success and longevity in adopting jurisdictions, compulsory arbitration has peaked in its adoption and has seemingly faded into the background of the alternative dispute resolution conversation. Neglecting or dismissing this vital tool in the …


National Security Law, Ogra Cadet, Geoffrey Goodale, Laurence R. Hull, Renee Latour, Barbara Linney, Jonathan Meyer, Guy C. Quinlan, Minji "Mj" Shin, Christopher Vallandingham, Bonnie C. Weinstein Sep 2026

National Security Law, Ogra Cadet, Geoffrey Goodale, Laurence R. Hull, Renee Latour, Barbara Linney, Jonathan Meyer, Guy C. Quinlan, Minji "Mj" Shin, Christopher Vallandingham, Bonnie C. Weinstein

The Year in Review

No abstract provided.


International Animal Law, Tala Dibenedetto, Edie Bowles, Paula Cardoso, Daina Bray, Rajesh K. Reddy, Regina Paulose Sep 2026

International Animal Law, Tala Dibenedetto, Edie Bowles, Paula Cardoso, Daina Bray, Rajesh K. Reddy, Regina Paulose

The Year in Review

No abstract provided.


International Human Rights, Daniel L. Appelman, John Regis Coogan, Cyreka Jacobs, Cailen Labarge, Corinne E. Lewis, Kerry Mclean, Hind Merabet, Linda S. Murnane, Thomas A. O'Keefe, Sara Sandford, Wendy Taube, James Taylor, Constance Z. Wagner Sep 2026

International Human Rights, Daniel L. Appelman, John Regis Coogan, Cyreka Jacobs, Cailen Labarge, Corinne E. Lewis, Kerry Mclean, Hind Merabet, Linda S. Murnane, Thomas A. O'Keefe, Sara Sandford, Wendy Taube, James Taylor, Constance Z. Wagner

The Year in Review

No abstract provided.


Middle East, Kelly Blount, Harry Baumgarten, Nicolas Bremer, Gaurav Redhal, Seyed Mohsen Rowhani, Howard L. Stovall, Catherine Van Kampen Sep 2026

Middle East, Kelly Blount, Harry Baumgarten, Nicolas Bremer, Gaurav Redhal, Seyed Mohsen Rowhani, Howard L. Stovall, Catherine Van Kampen

The Year in Review

No abstract provided.


Women's Interest Network, Julie King, Christine Korper, Abiola Afolayan, Marie Elena Angulo, Michela Cocchi, Angela M. Gallerizzo, Dolly Hernandez, Margaret Kamm, Dana Katz, Kendra Muller, Sierra Paola, Vanessa Romero Rocha, Aina Serret, Sandhya Taneja, Catherine Van Kampen Sep 2026

Women's Interest Network, Julie King, Christine Korper, Abiola Afolayan, Marie Elena Angulo, Michela Cocchi, Angela M. Gallerizzo, Dolly Hernandez, Margaret Kamm, Dana Katz, Kendra Muller, Sierra Paola, Vanessa Romero Rocha, Aina Serret, Sandhya Taneja, Catherine Van Kampen

The Year in Review

No abstract provided.


International Litigation, Jonathan I. Blackman, Carmine D. Boccuzzi, Theodore J. Folkman, Phillip B. Dye Jr., Matthew D. Slater, Mark Mcdonald, Ari Mackinnon, Igor V. Timofeyev, Joseph R. Profaizer Sep 2026

International Litigation, Jonathan I. Blackman, Carmine D. Boccuzzi, Theodore J. Folkman, Phillip B. Dye Jr., Matthew D. Slater, Mark Mcdonald, Ari Mackinnon, Igor V. Timofeyev, Joseph R. Profaizer

The Year in Review

No abstract provided.


International Criminal Law, International Courts, And Judicial Affairs, Manish N. Bhatt, Giovanni Chiarini, Katherine Maddox Davis, Beth Farmer, Timothy Franklin, Cyreka C. Jacobs, Stéphane De Navacelle, Sara L. Ochs, Alexander S. Vesselinovitch, Melissa Ginsberg, Marc Weitz, Julie Zorrilla Sep 2026

International Criminal Law, International Courts, And Judicial Affairs, Manish N. Bhatt, Giovanni Chiarini, Katherine Maddox Davis, Beth Farmer, Timothy Franklin, Cyreka C. Jacobs, Stéphane De Navacelle, Sara L. Ochs, Alexander S. Vesselinovitch, Melissa Ginsberg, Marc Weitz, Julie Zorrilla

The Year in Review

No abstract provided.


International Contracts, Deana Davis, Izak Rosenfeld, Alison Strongwater, Martin E. Aquilina, Vicky Li, Willem Den Hertog Sep 2026

International Contracts, Deana Davis, Izak Rosenfeld, Alison Strongwater, Martin E. Aquilina, Vicky Li, Willem Den Hertog

The Year in Review

No abstract provided.


Mexico, Kelsey Quigley, Josè Luis Lizárraga, John Walsh, Danielle Morris, Maria Camila Hoyos, David Ross, Lauren Mandell, Noah Guiney, Carlo Cannizzo, Enrique García, Vanessa Romero Sep 2026

Mexico, Kelsey Quigley, Josè Luis Lizárraga, John Walsh, Danielle Morris, Maria Camila Hoyos, David Ross, Lauren Mandell, Noah Guiney, Carlo Cannizzo, Enrique García, Vanessa Romero

The Year in Review

No abstract provided.


A Principled Approach To Equitable Compensation Undea Principled Approach To Equitable Compensation Under Erisa § 502(A)(3)R Erisa § 502(A)(3), Gabriel Juedemann Sep 2026

A Principled Approach To Equitable Compensation Undea Principled Approach To Equitable Compensation Under Erisa § 502(A)(3)R Erisa § 502(A)(3), Gabriel Juedemann

University of Chicago Law Review

In many cases, a beneficiary of an employee benefit plan suffers an injury due to a fiduciary’s misfeasance, but the beneficiary does not have a claim under ERISA’s benefit-recovery provision. In these circumstances, the beneficiary’s only path to relief is § 502(a)(3)’s authorization of “appropriate equitable relief.” But whether that provision permits monetary compensation when a beneficiary sues a fiduciary is a question the Supreme Court has not cleanly resolved, and circuit courts have fractured as a result.

This Comment argues that equitable compensation—or surcharge—should be available under § 502(a)(3) when a beneficiary sues a fiduciary, but only under certain …


Ai Slop, Jessica Silbey, Woodrow Hartzog Sep 2026

Ai Slop, Jessica Silbey, Woodrow Hartzog

Faculty Scholarship

The term “AI slop” has become popular to describe the output of generative AI systems seen as voluminous, low quality, or the result of little effort. When AI-generated music and videos flood platforms, they are called slop. Peer-reviewed journals and legal tribunals are drowning in low-quality and low-reliability AI slop submissions.  Employees are seen to be producing mountains of slop in their reports and communications with each other. The term has inertia and heft, and the phenomenon has significant consequences. Most of them are not good.

But the boundaries of “AI slop” and its usefulness in policy discussions are not …


Fireproofing The Fda: Power, Politics, And Public Health, Daniel G. Aaron Sep 2026

Fireproofing The Fda: Power, Politics, And Public Health, Daniel G. Aaron

Utah Law Review

On September 26, 2025, the S.J. Quinney College of Law hosted the Lee E. Teitelbaum Utah Law Review Symposium — Fireproofing the FDA: Power, Politics, and Public Health. The symposium is available on YouTube. Participants discussed problems longstanding and new in an attempt to chart a path for this vital agency. Topics included (1) What is the purpose of FDA?; (2) In what ways are the current Administration’s actions precedented or unprecedented?; (3) What is the current and ideal relationship between law and politics?; (4) How can law serve as an agent of public health?; and (5) How do we …


The Fda’S New Clinical Decision Support Software Guidance And Its Implications For Artificial Intelligence, Sara Gerke Sep 2026

The Fda’S New Clinical Decision Support Software Guidance And Its Implications For Artificial Intelligence, Sara Gerke

Utah Law Review

Artificial Intelligence (AI) is transforming healthcare. While the U.S. Food and Drug Administration (FDA) has authorized the marketing of more than 1,400 AI-based products classified as devices under Section 201(h)(1) of the Federal Food, Drug, and Cosmetic Act, many other AIbased products, including certain clinical decision support (CDS) software tools that provide recommendations to health care professionals about diagnosis, treatment, or prevention of a disease or condition, have been placed on the U.S. market without FDA premarket review. On January 6, 2026, the FDA issued a revised CDS Guidance, which superseded the September 28, 2022 CDS Guidance. Shortly after, the …


Fda In 2050: Best- And Worst-Case Scenarios, Michael S. Sinha Sep 2026

Fda In 2050: Best- And Worst-Case Scenarios, Michael S. Sinha

Utah Law Review

In 2025, the Trump administration disrupted many critical aspects of the biomedical research infrastructure in the United States. The Food and Drug Administration (FDA) was not spared. Robert F. Kennedy, Jr., a known vaccine denier with no health care experience, was confirmed as Secretary of the U.S. Department of Health and Human Services (HHS) in February 2025, followed by the confirmation of Dr. Martin Makary as Commissioner of the FDA in April. Departures of long-time FDA scientists, coupled with appointments of key personnel, seemingly because of their public stances on COVID-19 mRNA vaccines, have resulted in a tumultuous year for …


Fda Policymaking In The Trump Deregulation Era, Jordan Paradise J.D. Sep 2026

Fda Policymaking In The Trump Deregulation Era, Jordan Paradise J.D.

Utah Law Review

This Article endeavors to contribute to and continue the conversation about how the Trump deregulatory agenda is impacting a vital national public health agency, the FDA, and our national collective public health in ways that deviate from longstanding agency policy and practice. Various other FDA policy actions deserve concerted attention by legal scholars, including the agency’s recent moves in the direct-to-consumer marketing (DTC) drug space through targeted warning letters and publicity about reforming the “adequate provision” standards, food additives and generally recognized as safe (GRAS) listing processes and directives to industry, adjustments to the biosimilar interchangeability requirements through guidance document, …


Post-Approval Problems, Anjali D. Deshmukh M.D., J.D. Sep 2026

Post-Approval Problems, Anjali D. Deshmukh M.D., J.D.

Utah Law Review

Sitting across from 4-year-old Jessica’s parents, I whispered the truth: the most promising drug to fight their daughter’s disease was a therapy approved for adults, not for children her age. We could estimate the dose, monitor her organs, and hope the toxicity would not outpace the benefits, but there was no high-quality clinical trial data proving it was safe for kids like her yet, despite congressional mandates. Unexpected safety issues are often identified after drugs are approved and used outside of a closely controlled clinical trial, especially in understudied populations like children, the elderly, and pregnant women. When I asked …


Evaluating The Case Against Fda Independence, Patricia J. Zettler, Rachel E. Sachs Sep 2026

Evaluating The Case Against Fda Independence, Patricia J. Zettler, Rachel E. Sachs

Utah Law Review

Many former FDA officials, both politically-appointed leaders and those from the career ranks, as well as numerous FDA scholars have advocated for increased FDA independence in varied forms, and for good reason. At the same time, there are advantages to FDA’s current structure, and there may be ways to insulate career scientific experts’ decisions from political influence and to address other problems by generating independence, without overhauling the agency’s design. Policymakers should consider all options, as particular independence features may, or may not, be the best way, to address concerns about FDA’s capacity to carry out its vital public health …


A Primer Of Medical Device Regulation: How To Go From Reactive To Proactive To Better Protect Patient Safety, Sneha Dave, Rita F. Redberg Sep 2026

A Primer Of Medical Device Regulation: How To Go From Reactive To Proactive To Better Protect Patient Safety, Sneha Dave, Rita F. Redberg

Utah Law Review

FDA oversight of medical devices has too often been reactive, following preventable disasters rather than based on a proactive commitment to patient safety. The history of the device framework, the expansion of expedited pathways, weak postmarket surveillance, broad preemption, and conflicted patient advocacy together create a perfect storm of a regulatory environment that tolerates uncertainty and externalizes costs onto patients. Reforms such as time‑limited breakthrough status, mandatory and enforceable postmarket studies, requirements for more robust safety and efficacy data, and strengthened reporting duty for clinicians would move device regulation closer to FDA’s statutory mandate to protect public health. It would …


Medical Device Regulation: We Can’T Just Go Back (Nor Should We), George Horvath Sep 2026

Medical Device Regulation: We Can’T Just Go Back (Nor Should We), George Horvath

Utah Law Review

For much of the twentieth century, the federal Food and Drug Administration maintained its reputation as the preeminent regulatory agency, renowned for providing vigilant and scientifically rigorous oversight that ensured the safety and effectiveness of drugs and medical devices. But a former FDA commissioner recently lamented that “[t]he FDA as we’ve known it is finished.” Many commentators have raised concerns that reductions in force will leave the Agency understaffed, that these shortages will prolong review times, and that the standards applied to premarket evaluations of medical products will allow unsafe and ineffective products to reach the market. But in the …